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The contents of this data in brief are related to the article titled
“Matrix Rigidity Regulates the Transition of Tumor Cells to a Bone-
Destructive Phenotype through Integrin β3 and TGF-β Receptor
Type II”. In this DIB we will present our supplemental data
investigating Integrin expression, attachment of cells to various
adhesion molecules, and changes in gene expression in multiple
cancer cell lines. Since the interactions of Integrins with adsorbed
matrix proteins are thought to affect the ability of cancer cells to
interact with their underlying substrates, we examined the
expression of Integrin β1, β3, and β5 in response to matrix rigidity.
We found that only Iβ3 increased with increasing substrate
modulus. While it was shown that ﬁbronectin greatly affects the
expression of tumor-produced factors associated with bone
destruction (parathyroid hormone-related protein, PTHrP, and
Gli2), poly-l-lysine, vitronectin and type I collagen were also
analyzed as potential matrix proteins. Each of the proteins was
independently adsorbed on both rigid and compliant polyurethaneen access article under the CC BY license
/j.biomaterials.2015.06.026
Bone Biology, 2215b Garland Ave, 1235 MRBIV, Nashville TN 37235, USA.
A. Sterling).
J.M. Page et al. / Data in Brief 4 (2015) 440–446 441ﬁlms which were subsequently used to culture cancer cells. Poly-l-
lysine, vitronectin and type I collagen all had negligible effects on
PTHrP or Gli2 expression, but ﬁbronectin was shown to have a dose
dependent effect. Finally, altering the expression of Iβ3 demon-
strated that it is required for tumor cells to respond to the rigidity
of the matrix, but does not affect other cell growth or viability.
Together these data support the data presented in our manuscript
to show that the rigidity of bone drives Integrinβ3/TGF-β crosstalk,
leading to increased expression of Gli2 and PTHrP.
Published by Elsevier Inc. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableSubject area Biology
More speciﬁc subject
areaCancer biologyType of data Figures
How data was acquired ABI 7500 qPCR, western blot analysis, Image J software
Data format Analyzed
Experimental factors Adsorption of matrix proteins to PUR substrates, gene expression after silencing or over
expressing
Experimental features Gene expression of altered and unaltered bone-metastatic cancer cells was analyzed
Data source location Nashville, TN USA
Data accessibility The data is presented in this article and is related to [cite our article]Value of the data Utilizing different matrix proteins shows that the bone destructive gene expression is highly
speciﬁc to ﬁbronectin. Manipulation of Integrin expression affects PTHrP and Gli2 gene expression.
 Genetic manipulation of Integrin expression of MDA-MB-231 cells does not alter other metastatic
pathways or the growth potential of the cell lines.
1. Data
1.1. Gene expression changes in response to rigidity
The bone-metastatic breast cancer cell line MDA-MB-231, bone-metastatic lung cancer cell line
RWGT2, and the bone-metastatic prostate cancer cell line PC3 were used to test the effects of matrix
rigidity on gene expression of the bone destructive genes, PTHrP and Gli2. Integrin β3 was either over
expressed by an Iβ3 construct or inhibited in the MDA-MB-231 cell line by genetic inhibition using a
shRNA construct or pharmacological inhibition with LM609 or Cilengitide [1].
In addition to gene expression changes, Gli2 protein increases with respect to matrix rigidity
(Fig. 1A). While Integrin gene expression changes correlate with rigidity [2], in the bone-metastatic
MDA-MB-231 cells, Iβ1 and Iβ5 do not respond to matrix rigidity while Iβ3 increases with increasing
substrate modulus (Fig. 1B D). Thus the cells are interacting with the matrix primarily through Iβ3.1.2. Effects of adhesion Molecules on bone metastatic gene expression
Expression of Iβ3, Gli2, and PTHrP by MDA-MB-231 cells cultured on 2D compliant and rigid ﬁlms
and normalized to values measured for compliant ﬁlms is shown in Fig. 2. With the exception of PTHrP
Fig. 1. (A) Gli2 protein expression increases with respect to substrate modulus. (B–D) Integrin β3 mRNA expression changes
with increasing substrate modulus, while there is no change in Integin β1 and Integrin β5. (*po0.05, **po0.01, ***po0.005).
N¼3 biological replicates. Data presented as fold change over 3.8106 kPa for each gene.
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rigid and compliant ﬁlms for poly(L-lysine), vitronectin, or type I collagen.
1.3. Inhibiting Iβ3 decreases PTHrP and Gli2 gene expression
Genetic inhibition of Iβ3 with shRNA in MDA-MB-231 cells decreased Gli2 protein levels (Fig. 3A).
Additionally, pharmacological inhibition with LM609 or Cilengitide decreased Gli2 protein levels
(Fig. 3B and C). Similar results were seen for PTHrP and Gli2 when RWGT2 (black) or PC3 (white) cells
were treated with LM609 or Cilengitide (Fig. 3D–G).
1.4. Molecular modulation of Iβ3 expression
OE β3 cells showed increased PTHrP expression compared to mock-transfected control cells
(Fig. 4A). Additionally, when cultured on rigid and compliant PUR ﬁlms, the OE β3 cells showed no
statistical difference in PTHrP gene expression (Fig. 4B). Thus, the OE β3 and shβ3 cells were utilized as
model cell systems with high and low Integrin expression, respectively (Figs. 4C and D).
1.5. Effects of matrix rigidity on TGF-β RII expression
Expression of TGF-β RII by MCF-7 (negative control), MDA-MB-231, and RWGT2 cells was measured
by qPCR on rigid and compliant substrates. As anticipated, expression of TGF-β RII was signiﬁcantly
Fig. 2. Expression of PTHrP, Gli2, and Iβ3 by MDA-MB-231 cells on compliant and rigid PUR ﬁlms treated with poly(L-lysine),
vitronectin, or type I collagen. Gene expression was measured by qPCR. Data presented as fold change over compliant ﬁlms.
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differences in expression as a function of matrix rigidity for any of the three cell types (Fig. 5A).
1.6. Effects of Fn concentration on physical interactions between Iβ3 and TGF-βRII
The effects of Fn concentration on the FRET signal in MDA-MB-231 cells was measured for Fn
concentrations ranging from 0–50 μg/ml. The FRET signal was signiﬁcantly higher on rigid substrates
at all Fn concentrations (Fig. 5B).
1.7. Exogenous TGF-β stimulation of PTHrP and Gli2 is Iβ3-dependent
To investigate the role of TGF-β signaling in Iβ3 regulation of PTHrP and Gli2, RWGT2 or PC3 cells
were treated with the Integrin inhibitory antibody LM609 and given exogenous TGF-β. PTHrP and Gli2
were analyzed by qPCR. TGF-β stimulates PTHrP and Gli2 mRNA expression in RWGT2 (black) or PC3
(white) cells, but is unable to stimulate expression when Iβ3 is inhibited with LM609 (Fig. 6A and B)
suggesting that both TGF-β and Iβ3 are required for regulating PTHrP and Gli2.
1.8. Effects of silencing Iβ3 on growth of and bone metastatic gene expression by MDA-MB-231 tumor cells
As shown in Fig. 7A, shβ3 cells exhibited a growth rate similar to that of the mock-transfected
control. With the exception of Osteopontin (Opn), expression of bone metastatic genes by shβ3 cells
was similar to that by mock-transfected control cells (Fig. 7B).
Fig. 3. Gli2 western blot for (A) shβ3 cells or (B–C) MDA-MB-231 cells treated with Cilentide or LM609. (D–G) PTHrP (D-E) or
Gli2 (F-G) mRNA expression for RWGT2 cells (black) or PC3 cells (white) treated with Cilengitide or LM609. (*po0.05,
**po0.01). N¼3 biological replicates. Data presented as fold change over untreated.
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2.1. Western blot analysis
Cells were harvested 24 h after seeding on PUR substrates in a radioimmunoprecipitation buffer
containing a cocktail of protease and phosphatase inhibitors (Pierce). Equal protein concentrations
were prepared for loading with NuPAGE sample buffer (Life Technologies) and separated on a 10%
SDS-PAGE gel (BioRad). Proteins were transferred to a PVDF membrane and blocked with 5% BSA in
TBS containing 0.1% Tween-20 for 1 h at room temperature, followed by incubation with anti-Gli2
antibody (1:1000, SantaCruz) overnight at 4 1C. After washing, membranes were blotted with anti-
goat IgG (1:2000, SantaCruz), and bands were detected by enhanced chemiluminescence using an In-
Vivo MS FX Pro (Bruker). Membranes were then stripped and reprobed using an antibody for β-actin
(1:5000, Sigma) as a loading control. Analysis was performed using Image J software.2.2. Quantitative real-time PCR
To measure changes in gene expression, mRNA reverse transcription was carried out using the
qScript cDNA synthesis kit (Quanta, VWR) per manufacturer's instructions. Brieﬂy, cells were
harvested with trypsin after 24 h in culture and total RNA was extracted using the RNeasy Mini Kit
Fig. 4. Expression of PTHrP and Iβ3 in genetically modiﬁed MDA-MB-231 cells. (A) OE β3 cells over-express Iβ3 compared to the
mock-transfected control. (B) Effect of rigidity on expression of PTHrP by OE β3 cells. (C) shβ3 cells express signiﬁcantly low Iβ3
compared to the mock-transfected control. (D) OE β3 cells express signiﬁcantly higher Iβ3 compared to the mock-transfected
control. (npo0.05, nnpo0.01). N¼3 biological replicates. Data presented as fold change over untreated or compliant.
Fig. 5. (A) Effects of matrix rigidity on TGF-β RII expression by MCF-7 (white), MDA-MB-231 (gray) and RWGT2 (black) cells.
(B) Effects of Fn concentration on the FRET signal for MDA-MB-231 cells.
J.M. Page et al. / Data in Brief 4 (2015) 440–446 445(Qiagen). The qScript cDNA supermix was used to synthesize cDNA using 1 mg total RNA. The
expression of PTHrP, Gli2, Iβ1, Iβ3, Iβ5, and TGF-β RIIwas measured in triplicate by quantitative qRT-PCR
using validated TaqMan primers with the 7500 Real-Time PCR System (Applied Biosciences) using the
following cycling conditions: 95 1C for 15 s and 60 1C for 1 min, preceded by an initial incubation
period of 95 1C for 10 min. Quantiﬁcation was performed using the absolute quantitative for human
cells method using 18S as an internal control.
Fig. 7. Effects of silencing Iβ3 on tumor cell growth and bone metastatic gene expression. (A) Cell growth. (B) Bone metastatic
gene expression.
Fig. 6. (A) PTHrP and (B) Gli2mRNA expression for RWGT2 (black) or PC3 (white) cells treated with LM609 and given exogenous
TGFβ. (*po0.05, **po0.01, ***po0.005). N¼3 biological replicates. Data presented as fold change over untreated.
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In addition to ﬁbronection (Fn), compliant and rigid PUR ﬁlms were incubated with a 4 mg/mL
solution of vitronectin, type I collagen, or poly(L-lysine) in PBS overnight at 4 1C to mediate cell
adhesion. MDA-MB-231 cells were cultured on the ﬁlms for 48 h. Expression of Iβ3, Gli2, and PTHrP
was measured by qPCR relative to the control 18S.
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